Robert L. Zerbe, M.D.
Robert Zerbe has served on our board of directors since May 2016. Dr. Zerbe has served as a member of the board of directors of Vericel Corporation, a developer of patient-specific expanded cell therapies for severe diseases and conditions, since January 2006 and as chairman of the board of directors since October 2012. Until July 2016, Dr. Zerbe was the chief executive officer of QUATRx Pharmaceuticals Company, or QUATRx, a drug development company he co-founded in 2000. Prior to his role at QUATRx, Dr. Zerbe held several senior executive management positions with pharmaceutical companies including Eli Lilly and Company, from 1982 to 1993, and Pfizer (formerly Parke-Davis) from 1993 to 2000. During his tenure at Eli Lilly and Company, Dr. Zerbe’s clinical research and development positions included managing director, Lilly Research Center U.K., and vice president of clinical investigation and regulatory affairs. He joined Parke-Davis in 1993, becoming senior vice president of worldwide clinical research and development. Dr. Zerbe has also served on the board of managers of Metabolic Solutions Development Company, LLC since 2015. Dr. Zerbe received his M.D. from the Indiana University School of Medicine, and has completed post-doctoral work in internal medicine, endocrinology and neuroendocrinology at Indiana University and the National Institutes of Health.